BTAI
BioXcel Therapeutics (BTAI)
$59
About BioXcel Therapeutics (BTAI)
BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.
Details
Daily high
$0.58
Daily low
$0.55
Price at open
$0.55
52 Week High
$5.62
52 Week Low
$0.50
Market cap
22.4M
Dividend yield
0.00%
Volume
256,281
Avg. volume
714,779
P/E ratio
-.15
BioXcel Therapeutics News
Details
Daily high
$0.58
Daily low
$0.55
Price at open
$0.55
52 Week High
$5.62
52 Week Low
$0.50
Market cap
22.4M
Dividend yield
0.00%
Volume
256,281
Avg. volume
714,779
P/E ratio
-.15